Daniela Hommel - CompuGroup Medical Chief Officer
| 0MSD Stock | 16.22 6.76 29.42% |
Executive
Daniela Hommel is Chief Officer of CompuGroup Medical AG
| Age | 50 |
| Address | Maria Trost 21, Koblenz, Germany, 56070 |
| Phone | 49 261 8000 0 |
| Web | https://www.cgm.com |
CompuGroup Medical Management Efficiency
The company has return on total asset (ROA) of 0.0305 % which means that it generated a profit of $0.0305 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0379 %, meaning that it generated $0.0379 on every $100 dollars invested by stockholders. CompuGroup Medical's management efficiency ratios could be used to measure how well CompuGroup Medical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, CompuGroup Medical's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 1.8 B in 2025, whereas Other Assets are likely to drop slightly above 19.3 M in 2025.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Bart Luijten | Sligro Food Group | 57 | |
| Rob Abraham | Supermarket Income REIT | N/A | |
| Natalie Markham | Supermarket Income REIT | 52 | |
| Carcie Rogers | Supermarket Income REIT | N/A | |
| Robert Abraham | Supermarket Income REIT | N/A | |
| Anja Bree | Sligro Food Group | 52 | |
| Alex OConnell | Fevertree Drinks Plc | N/A | |
| Gerrie Veeken | Sligro Food Group | 64 | |
| de Rooij | Sligro Food Group | N/A | |
| Kees Kiestra | Sligro Food Group | 56 | |
| Yolanda Cerezo | Ebro Foods | N/A | |
| Rosie Lister | Supermarket Income REIT | N/A | |
| Jansen | Sligro Food Group | N/A | |
| Verlouw | Sligro Food Group | N/A | |
| Alfonso Barro | Ebro Foods | N/A | |
| Thomas Lindegaard | Scandinavian Tobacco Group | N/A | |
| Lars Wassberg | Scandinavian Tobacco Group | N/A | |
| Bert Vanmoortel | Sligro Food Group | 42 | |
| Claire Huntingford | Fevertree Drinks Plc | 43 | |
| Isabelle Smith | Supermarket Income REIT | N/A | |
| Alfonso Barr | Ebro Foods | N/A | |
Management Performance
| Return On Equity | 0.0379 | ||||
| Return On Asset | 0.0305 |
CompuGroup Medical Leadership Team
Elected by the shareholders, the CompuGroup Medical's board of directors comprises two types of representatives: CompuGroup Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CompuGroup. The board's role is to monitor CompuGroup Medical's management team and ensure that shareholders' interests are well served. CompuGroup Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CompuGroup Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Angela Teufer, Connectivity DACH | ||
| Ulrich Thome, MD Board | ||
| Daniela Hommel, Chief Officer | ||
| Emanuele Mugnani, MD Board | ||
| Helge Wei, Senior Connectivity | ||
| Hannes Reichl, MD Board | ||
| Alexander Weimer, Head Communications | ||
| Michael Franz, Co Communication | ||
| Daniel Gotthardt, CEO MD | ||
| Oliver Bruzek, Chief Affairs | ||
| Stefanie Peters, Member SE | ||
| MBA LLM, CFO, CEO | ||
| Claudia Thom, Corporate Relations | ||
| Eckart Pech, MD Board |
CompuGroup Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CompuGroup Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0379 | ||||
| Return On Asset | 0.0305 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 1.96 B | ||||
| Shares Outstanding | 49.56 M | ||||
| Shares Owned By Insiders | 56.06 % | ||||
| Shares Owned By Institutions | 25.00 % | ||||
| Price To Sales | 1.69 X | ||||
| Revenue | 1.19 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CompuGroup Stock Analysis
When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.